Roth Capital cuts Annovis Bio price target to $7
Roth Capital cut its price target on Annovis Bio to $7.00/share from $8.00.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.